General Comments / Chat, page-7155

Do you think it's possible RAC have given up on the EMD AML trial? We're at the point now where we were hoping to maybe start seeing initial readouts, but almost a year has passed without dosing a single patient or opening up even one additional site.

Could they have looked at the estimated expense ($7.7-$15.4 million) and decided that money is better utilised in some other way given the difficulties that they've obviously faced with this trial?

That may all be well and good of course, but I'm hoping we don't have any problems with the IV formulation given the recently elevated prominence of Cardio in plans going forward. If we're putting most or all of our eggs in that basket it's high risk until that formulation is proven.